EBV-activation of human B-lymphocytes.
暂无分享,去创建一个
G. Klein | P. Åman | M. Nordström | N. Lewin
[1] J. Habeshaw,et al. Expression of burkitt lymphoma‐associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal‐centre B cells , 1985, International journal of cancer.
[2] T. Schulz,et al. Growth control of activated, synchronized murine B cells by the C3d fragment of human complement , 1985, Nature.
[3] S. Swerdlow,et al. Distribution of B lymphocyte subsets in normal lymphoid tissue. , 1984, Clinical and experimental immunology.
[4] G. Klein,et al. Epstein-Barr virus susceptibility of normal human B lymphocyte populations , 1984, The Journal of experimental medicine.
[5] I. Magrath,et al. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals. , 1982, Journal of immunology.
[6] A G Bird,et al. A New Approach to the Study of Human B Lymphocyte Function Using an Indirect Plaque Assay and a Direct B Cell Activator , 1979, Immunological reviews.
[7] W. Leibold,et al. Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation , 1976, Infection and immunity.
[8] G. Klein,et al. Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines , 1973, International journal of cancer.
[9] P. Åman,et al. TPA (12-O-tetradecanoyl-phorbol-13-acetate) activation and differentiation of human peripheral B lymphocytes. , 1984, Immunology.